S
everal single nucleotide polymorphisms in human organic cation transporter 1 (hOCT1) (1, 2) and in human organic cation transporter 2 (hOCT2) (3) genes have been recently found. The functional analysis of these variants expressed in Xenopus laevis oocytes showed that C88R and G401S mutants increased the Michaelis-Menton constant (K m ) and reduced the V max of hOCT1 (1) , whereas A270S decreased and R400C and K432Q mutants increased the affinity of hOCT2 (3) . For hOCT1, it could be shown that variants which reduced or eliminated the function (R61C, P341L, G220V, G401S, and G465R) had alterations in evolutionary conserved amino acid residues (4) . Because some consensus sequences for protein kinases are conserved in all organic cation transporters (OCT) (5) , single nucleotide mutations could also modify regulation of the transporter. For this reason, understanding regulation mechanisms of OCT on the molecular level is mandatory.
Protein kinase C (PKC) activation has been reported to have diverse effects on organic cation transport across the basolateral membrane: In rabbit proximal tubules PKC activation stimulated transport activity (6) and in human proximal tubules it inhibited (7) transport activity. Furthermore, in HEK293 cells stably expressing the OCT1 of the rat (rOCT1), the activity of the transporter is stimulated by PKC, protein kinase A (PKA), p56 lck tyrosine-kinase (8) and inhibited by cGMP (9) . PKC has been shown to directly phosphorylate rOCT1, leading to a conformational change at the substrate binding site (8) : PKCmediated phosphorylation increased the apparent affinities of rOCT1 for various substrates. However, in HEK293 cells stably expressing the hOCT2, PKC seemed not to stimulate the transporter, whereas its activity was reduced by PI3K and PKA activation and was stimulated by an endogenously active calmodulin-dependent signaling pathway (10) . Similar results have been obtained with HEK293 cells stably expressing hOCT1 (11) or the human extraneuronal monoamine transporter (or hOCT3) (12) , which were not affected by PKC activation but again were inhibited by PKA and stimulated by an endogenously active calmodulin-dependent signaling path-way. These findings suggest different regulation pathways of OCTs. Regulation of these transporters has great physiological and even clinical significance for the secretion of multiple endogenous metabolites, drugs, and xenobiotics. Stimulation of this process can accelerate detoxification, whereas inhibition can prolong the exposition of the body to dangerous substances (13) .
The rOCT1 is a 556 -amino acid membrane protein (14) mapped to chromosome 1q11-12 (15) , which has been identified by Northern blot analysis in rat kidney, small intestine, colon, and liver (14) . In the kidney, it has been localized at the basolateral membrane of S1 and S2 segments of proximal tubules (16) . The transport mediated by rOCT1 has been characterized as electrogenic, independent of Na ϩ and pH, and bidirectional by radioactive tracer flux measurements with oocytes from Xenopus laevis expressing rOCT1 (17) . rOCT1 can translocate organic cations like TEA ϩ and choline (18) , cathecolamines (19) , and nucleosides like 2Ј-deoxytubercidin (20) , whereas cations like tetrapentylammonium (TPA ϩ ) and cyanine 863 are nontransported inhibitors of the transporter (21) . For this transport protein 12 transmembrane domains, a large hydrophilic extracellular loop between the first and the second predicted transmembrane domain and an intracellular localization of the Nand C-termini have been described (22) . rOCT1 possesses five putative PKC phosphorylation sites (S286, S292, T296, S328, and T550) (23) and, according to the PROSITE prediction program (24), three PKA phosphorylation sites (T297, T348 and T537) and one tyrosine-kinase phosphorylation site (Y545) (Figure 1) . To elucidate the mechanisms underlying stimulation of transport activity by PKC activation and to determine which of the five putative phosphorylation sites is responsible for the regulation and the PKC-induced shift in substrate affinities of rOCT1, we compared the functional properties and the regulation of rOCT1 stably expressed in HEK293 cells after sitedirected mutagenesis of single PKC-sites (S286A, S292A, T296A, S328A, and T550A) or of all PKC sites (5x-PKC) to alanine with wild-type (WT) rOCT1.
Materials and Methods

Construction of rOCT1 Mutants
rOCT1 variants carrying mutations in the putative PKCphosphorylation sites were constructed by the PCR using as a template the plasmid rOCT1/pRcCMV (25) . All single mutants were prepared by the overlap extension method (26) . The PCR amplificates were digested with NheI and Eco81I (for mutants S286A, S292A, T296A, and S328A) or with Cfr42I and NotI (for T550A) and cloned directly into the plasmid rOCT1/pRcCMV treated with the same restriction endonucleases. To create the rOCT1 variant in which all five PKC-sites are mutated (5x-PKC), at first the triple mutant S286A/S292A/T296A was performed using megaprimer strategy (27) . PCR amplificate was digested with restriction endonucleases NheI and Eco81I and cloned into the rOCT1/pBluescript II SK plasmid cut with the same enzymes. The same strategy was used to combine these three mutations and S328A in one construct, quadruple mutant S286A/S292A/T296A/S328A. The quadruple mutant was then cloned into the eukaryotic expression vector pRcCMV (Invitrogen, The Netherlands). The 5x-PKC variant was finally obtained combining the quadruple mutant and T550A into one construct in the pRcCMV vector using Eco81I and HindIII.
HEK293 Cell Culture
The HEK293 cells (human embryonic kidney cortex cells, CRL-1573; American Type Culture Collection, Rockville, MD) stably expressing WT, 5x-PKC, and single-mutant rOCT1 were transfected as described previously (25) . Cells were grown at 37°C in 50-ml cell culture flasks (Greiner, Frickenhausen, Germany) in DME (Biochrom, Berlin, Germany) containing 3.7 g/L NaHCO 3 , 1.0 g/L D-glucose, and 2 mmol L-glutamine (Life Technologies BRL/Life Technologies, Eggenstein, Germany) gassed with 8% CO 2 . To this medium 100,000 U/L penicillin, 100 mg/L streptomycin (Biochrom), 10% fetal calf serum, and 0.8 mg/ml geneticin (Life Technologies BRL/Life Technologies) were added. Experiments were performed after 4 to 8 d with cells grown on glass cover slips of the passages 11 to 42. Culture and functional analysis of these cells was approved by the Landesumweltamt Nordrhein-Westfalen, Essen, Germany (521-M-1.14/00).
Fluorescence Measurements with 4-(4-(dimethylamino)styryl)-N-methylpyridinium
As substrate for OCTs, the fluorescence organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP ϩ ) was used. Fluorescence measurement device and experimental procedures were as customary in our laboratory (7, 8, 11 changes in emission spectrum, and bleaching of the dye (7, 8) .
For this reason, we evaluated the initial linear slope of the first 10 to 30 s as transport parameter. To study regulation of ASP ϩ uptake, monolayers were incubated for 10 min with the respective agonists or inhibitors before ASP ϩ was added in the continued presence of these substances.
Effect of PKC Stimulation on Trafficking of rOCT1
The same number of cells (WT or 5x-PKC) of same passage and age were incubated 10 min with or without 1 mol sn1,2-dioctanoyl glycerol (DOG) at 37°C. After incubation, cells were washed three times with ice-cold Ringer buffer and fixed for 1 h with 4% paraformaldehyde pH 7.4. After washing three times with ice-cold Ringer buffer, the unspecific binding sites were blocked by 1 h incubation at 22°C with Ringer buffer containing 0.5% gelatin (Amersham Biosciences Europe, Freiburg, Germany). Finally, cells were incubated overnight at 4°C with affinity-purified antibodies against the extracellular region of the transporter (22) 
Immunoprecipitation of rOCT1 and Detection of Phosphorylated Transporters
Immunoprecipitation with anti rOCT1 antibodies was performed as described previously (28) . Briefly, after 15 min incubation of the same number of WT or of 5x-PKC cells of same age and passage with or without 1 mol DOG at 37°C, cells were washed three times with cold PBS and solubilized in lysis buffer (in mmol: 20 Tris-HCl pH 7.5, 25 NaCl, 50 NaF, 15 Na 4 P 2 O 7 , 1 EDTA, 2 Na 3 VO 4 containing 1% Triton X100, 44 g/ml PMSF, and a cocktail of protease inhibitors). After centrifugation at 10,000 ϫ g for 15 min, lysates were incubated with gentle shaking 2 h with 10 l affinity-purified antibodies against the extracellular region of the transporter (22) and then 2 h with 40 l protein G-Agarose. All procedures were performed at 4°C. The immunocomplexes bound to the beads were recovered by centrifugation, washed five times with lysis buffer, resuspended in Laemmli buffer, denaturated at 95°C for 5 min, and loaded onto 8 to 16% SDS-polyacrylamide gels (PAGEr Gold Precast Gels; Cambrex, Rockland, ME) for Western blot analysis or phosphoprotein determination. For Western blot analysis, the proteins on the gel were transferred to a polyvinylidene difluoride (PVDF) membrane incubated with blocking reagent (Amersham, Freiburg, Germany). After incubation with the primary antibody (goat-polyclonal antibody to hOCT1; Santa Cruz Biotechnology, Santa Cruz, CA), membranes were incubated with rabbit anti-goat horseradish peroxidase-conjugate (Southern Biotechnology, Birmingham, AL) and covered with SuperSignal (Pierce, Bonn, Germany) before exposure (Lumimager, Roche Diagnostics, Mannheim, Germany). For in-gel detection of phosphate groups attached to tyrosine, serine, or threonine and of total proteins, the Pro-Q Diamond phosphoprotein and the Sypro Ruby gel stains (Molecular Probes, Leiden, the Netherlands), respectively, were sequentially used with the same gel according to the instructions of the manufacturer. Gels were imaged with a Typhoon 9400 scanner (Amersham, Freiburg, Germany).
Chemicals
Forskolin was obtained from Sigma (Taufkirchen, Germany); aminogenestein and DOG were purchased from Calbiochem (Bad Soden, Germany); gelatin was obtained from Amersham (Freiburg, Germany); ASP ϩ and Alexa Fluor 488 F(abЈ) 2 fragment of goat anti-rabbit IgG were obtained from Molecular Probes (Leiden, The Netherlands). All other substances and standard chemicals were obtained from Sigma or Merck (Darmstadt, Germany).
Statistical Analyses
Data are presented as mean values Ϯ SEM with n referring to the number of monolayers used in fluorescence measurements. EC 50 values were obtained by sigmoidal curve fittings (GraphPad InStat, San Diego, CA) and were compared using one-way ANOVA. Effects of treatment on the EC 50 of concentration response curves were compared using GraphPad Prism, San Diego, CA. Unpaired or paired two-sided t test was used to prove statistical significance of the effects. P Ͻ 0.05 was considered statistically significant.
Results
Regulation of rOCT1 by Protein Kinases
Stimulation of PKC with 1 mol DOG resulted in a significant increase of ASP ϩ uptake in cells expressing WT-rOCT1 (ϩ92 Ϯ 26%, n ϭ 18), whereas no significant effect could be observed in cells expressing mutated transporters (S286A: Ϫ9 Ϯ 4%, n ϭ 22, S292A: Ϫ14 Ϯ 6%, n ϭ 19, T296A: Ϫ9 Ϯ 13%, n ϭ 20, S328A: Ϫ11 Ϯ 6%, n ϭ 15, T550A: Ϫ15 Ϯ 20%, n ϭ 21, 5x-PKC: Ϫ7 Ϯ 24%, n ϭ 11) (Figure 2a) . Activation of PKA with 1 mol forskolin significantly stimulated ASP ϩ uptake in WT (ϩ60 Ϯ 21%, n ϭ 13), T296A (ϩ59 Ϯ 27%, n ϭ 19), and T550A (ϩ69 Ϯ 22%, n ϭ 13), but not in S286A (Ϫ8 Ϯ 8%, n ϭ 31), S292A (Ϫ7 Ϯ 7%, n ϭ 31), S328A (Ϫ8 Ϯ 10%, n ϭ 15), and 5x-PKC cells (ϩ8 Ϯ 12%, n ϭ 12) (Figure 2b) . Inhibition of the p56 lck tyrosine kinase with 10 mol aminogenestein significantly reduced ASP
ϩ uptake in all cells tested (WT: Ϫ47 Ϯ 8%, n ϭ 11, S286A: Ϫ73 Ϯ 3%, n ϭ 10, S292A: Ϫ54 Ϯ 5%, n ϭ 10, T296A: Ϫ45 Ϯ 4%, n ϭ 12, S328A: Ϫ60 Ϯ 7%, n ϭ 9, T550A: Ϫ57 Ϯ 10%, n ϭ 12, 5x-PKC: Ϫ74 Ϯ 4%, n ϭ 11) (Figure 2c ).
Substrate Specificity
The substrate specificities of the different forms of rOCT1 have been determined by studying inhibition of ASP ϩ uptake by known substrates or inhibitors of organic cation transport (Figure 3) , like TEA ϩ (Figure 4 ), TPA ϩ ( Figure 5 ), and quinine ( Figure 6 ). TEA ϩ inhibited ASP ϩ uptake in a concentrationdependent manner in WT and all rOCT1 mutants. The S292A mutant displayed the highest and T296A mutant the lowest apparent affinity for TEA ϩ (Table 1) . When compared with ANOVA, the EC 50 values for TEA ϩ of WT were not different from those obtained in S286A and S292A, but were significantly different from those obtained with the other mutants. The inhibition curves obtained with T296A, S328A, and T550A had a shallower slope than those obtained with WT ( Figure 4) . TPA ϩ and quinine also inhibited ASP ϩ uptake in a concentration-dependent manner in all forms of rOCT1 ( Figures 5 and 6 , respectively). The WT had the highest apparent affinity for TPA ϩ and quinine, and S328A the lowest (Table 1) . When compared with ANOVA, all EC 50 values obtained with mutated rOCT1 were significantly different from those obtained with WT (Table 1) ; moreover, the curves obtained with T296A were shallower than the others ( Figures 5 and 6, respectively) . We have previously demonstrated that activation of PKC shifted the concentration-response curves for the inhibition of ASP ϩ uptake by TEA ϩ , TPA ϩ , and quinine to the left, causing a decrease in the EC 50 value by more than one order of magnitude (8) , indicating that the increase in transport is caused by an increase in rOCT1 apparent affinity. In this study, we have therefore tested also whether mutations of the potential PKCphosphorylation sites abolished this effect. The TEA ϩ and quinine inhibition curves of ASP ϩ uptake without or with DOG incubation in T296A (EC 50 in mol without DOG: TEA ϩ 1135, Figure 7c) were not statistically different. The same was found with S286A, S292A, and S328A, in which PKC activation did not change the apparent affinity for TEA ϩ (EC 50 in mol without DOG: 153, n ϭ 4 to 13; 56, n ϭ 4 to 13 and 484, n ϭ 7 to 23; with DOG: 109, n ϭ 9 to 14; 99, n ϭ 5 to 9 and 291, n ϭ 5 to 10, respectively; Table 1 ). Because the regulatory pathway linked to the p56 lck tyrosine kinase is active in WT and all mutants (as shown by the experiments with aminogenestein), we have tested if this regulation is also associated with changes in transporter affinity. The concentrationresponse curves for ASP ϩ uptake inhibition by TEA ϩ with or without aminogenestein incubation in WT were not significantly different (EC 50 without aminogenestein: 68 mol, n ϭ 8 to 34; with aminogenestein: 69 mol, n ϭ 7 to 11). Figure 8a shows the effects of incubation with 1 mol DOG on the membrane-associated fluorescence in WT and 5x-PKC cells. Activation of PKC with DOG caused no significant increase of cell-associated fluorescence in WT and also in 5x-PKC cells. Exposition of the intracellular transporter pool by cell permeabilization resulted in a small but significant increase of fluorescence (10 Ϯ 2%, n ϭ 4, Figure 8b ).
Effect of PKC Stimulation on Trafficking of rOCT1
Immunoprecipitation of rOCT1 and Detection of Phosphorylated Transporters
After stimulation of PKC with DOG, rOCT1 phosphorylation in WT increased substantially, whereas it remained unchanged in 5x-PKC (Figure 9a ). Total protein was the same with or without DOG for WT-and also for 5x-PKC-cells (Figure 9b ). Western blot analysis confirmed the presence of rOCT1 at an apparent molecular weight of 70 KDa (Figure 9c ).
Discussion
OCT play an essential role in controlling concentration of endogenous and exogenous positively charged metabolites in the body fluids. In the kidney, OCT represent an important detoxification pathway for many potentially harmful sub- ϩ by WT (n ϭ 5 to 17), S286A (n ϭ 6 to 15), S292A (n ϭ 7 to 13), T296A (n ϭ 4 to 14), S328A (n ϭ 7 to 11), T550A (n ϭ 5 to 9) and 5x-PKC (n ϭ 7 to 21) cells. Data are presented as initial slope (mean values Ϯ SEM) of the uptake in percent of control experiments performed at the same day with cells of the same passage and age. n indicates the number of monolayers used. EC 50 values are also indicated.
stances. For these reasons, regulation of their activity has a great physiological and pathophysiological significance. These transporters have a species-specific organ localization of the different isoforms: For example, in the rat the principal renal isoform is isoform 1, whereas in humans it is isoform 2 (29) .
All OCT possess several potential PKC-phosphorylation sites in the intracellular loops of the molecule (5), suggesting a role for PKC in the regulation of OCT activity. However, different isoforms have a different pattern of PKC sites (29) . This can explain why different isoforms are differently regulated. hOCT1 (11), hOCT2 (10) , and hOCT3 (12) , for example, are not activated by PKC stimulation, but by various other regulatory pathways such as PKA or Ca 2ϩ -calmodulin (10, 12) . In this study, we attempted to determine which of the described five putative PKC sites (23) is responsible for PKC-mediated regulation of rOCT1 and whether transporter phosphorylation changes substrate affinities. Properties and regulation of cation transport of rOCT1 stably expressed in HEK293 cells after site-directed mutagenesis of the single PKC-sites S286, S292, T296, S328, and T550, or of all PKC-sites to alanine have been compared with wild-type rOCT1. The experiments on apparent substrate affinities show that each of the five mutations of the putative PKC-phosphorylation sites has different effects on the apparent affinity of the transporter for its substrates, even though the rank order of affinity was not changed being always TPA ϩ Ͼ quinine Ͼ TEA ϩ . However, the ratios between the EC 50 values of the mutants and of the WT-rOCT1 (Table 1) show that different mutations change apparent substrate affinities to different extents: T296A caused the highest change in TEA ϩ affinity, whereas for TPA ϩ and quinine the biggest Ratios of EC 50 values obtained with mutated transporters and with those of WT-rOCT1 are presented in italics. PKC indicates protein kinase C; WT, wild-type; DOG, sn1,2-dioctanoyl glycerol.
Effects of activation of PKC with 1 mol DOG on the apparent affinities of the transporters for TEA ϩ are also reported. *Significant differences from WT (one-way ANOVA, P Ͻ 0.05). † Significant differences from nonstimulated cells (F test, P Ͻ 0.05; GraphPad Prism, San Diego, CA). ϩ by T296A-(a), T550A-mutants (b) and 5x-PKC (c) under control conditions (closed squares, n ϭ 6 to 20; n ϭ 11 to 17; n ϭ 10 to 58 and closed triangles, n ϭ 4 to 14; n ϭ 5 to 8; n ϭ 7 to 21 for T296A, T550A, and 5x-PKC, respectively) and after incubation with 1 mol DOG for 10 min (open squares, n ϭ 8 to 14; n ϭ 10 to 15; n ϭ 6 to 17 and open triangles, n ϭ 4 to 9; n ϭ 6 to 11; n ϭ 7 to 15 for T296A, T550A, and 5x-PKC, respectively). Data are presented as initial slope (mean values Ϯ SEM) of the uptake in percent of control experiments performed at the same day with cells of the same passage and age. The curves in the presence of DOG are not significantly different from the respective curves without DOG. change in affinity could be observed with S328A. The shift of apparent affinities was in T550A of the same order of magnitude for all tested substrates, suggesting that this mutation influences mainly the ASP ϩ recognition site in the binding pocket of the rOCT1. In S286A and S292A, there was no significant change of the apparent affinity for TEA ϩ ; however, those for quinine and, to a greater extent, for TPA ϩ were significantly lower than in WT. The results of this study show that mutations in the regulatory residues of the intracellular domains of the molecule influence to different extents the binding of various substrates. This confirms the notion of a large binding pocket with partially overlapping interaction domains for different substrates and inhibitors of OCT types, as also proposed on the basis of other site directed mutagenesis experiments (30, 31) . Modeling of the substrate binding regions of rOCT1 using the tertiary structure of the lactose permease from Escherichia coli supports this view (31) . More importantly, these findings indicate that the large intracellular loop containing the PKC sites is part of the binding pocket of the rOCT1 or closely interacts with it. Other evidence supporting and extending this view to other OCT types come from electrophysiological studies: In oocytes expressing rOCT2, tetrabutylammonium had a significantly higher affinity from the outside compared with the inside, whereas corticosterone had a higher affinity from the inside compared with the outside (32) . These experiments with the mutated transporters confirm the importance of PKC in the regulation of rOCT1: After site-directed mutagenesis of all five putative PKC-phosphorylation sites, activation of PKC by DOG did not stimulate more ASP ϩ uptake. Detection of phosphory- tracellular pool of rOCT1 accounts only for 10% of the total number of transporters. Because this intracellular pool is relative small, it is unlikely that recruitment of this pool can explain the large effect of PKC activation on rOCT1 activity. For many other transporters and ion channels, regulation via different mechanisms is long known. Direct phosphorylation of multiple canonical sites has been suggested for PKC-induced regulation of antidepressant-sensitive serotonin transporters (33) . Stimulation of PKC decreased the activity of the human organic anion transporter 1 (hOAT1) transiently expressed in Xenopus laevis oocytes or HEK293 cells. This regulatory effect is achieved through carrier retrieval from the cell membrane and does not involve phosphorylation of the seven predicted hOAT1 PKC sites (34) . Even if some of the consensus PKC sites are conserved in some OAT types and OCT types, there is a sharp divergence in their regulation. Therefore, rather than the presence of determined single residues, the overall complex of potential PKC sites (never the same in different isoforms of ion transporters) on the intracellular domain may be important to determine if and how a transporter is regulated. It also could be speculated that modifications in one or more putative PKC sites prevents phosphorylation of another site by sterical alteration of the molecule. Such sterical influences on functional properties of rOCT1 are also evident from changes in PKA sensitivity seen with some of these mutations in putative PKC sites. The PKA-mediated regulation of rOCT1 was still active in T296A and T550A mutants, but not in S286A, S292A, and S328A mutants. Inhibition of p56 lck tyrosine kinase with aminogenestein significantly reduced ASP ϩ uptake in all mutants tested. The regulation through this pathway is not influenced by PKC site mutations, probably because the regulatory effect of p56 lck tyrosine kinase is not associated with affinity changes of the transporter, as demonstrated by experiments in which concentration-response curves for ASP ϩ uptake inhibition by TEA ϩ under aminogenestein incubation in WT were compared with those obtained without aminogenestein incubation. Further studies are necessary to demonstrate that regulation of rOCT1 activity via tyrosin kinases also involves direct phosphorylation of the transporter as in the case for PKC-mediated activation or whether this activation involves altered trafficking of the molecule to the plasma membrane as shown, e.g., for organic anion transporters (34) . Because different organic cations may have different interaction sites in rOCT1 binding pocket, such regulatory mechanisms may have more or less pronounced effects on different substrates. Activation of PKC with DOG did not change apparent affinities of mutated rOCT1 for TEA ϩ and quinine more, in contrast to what was found with WT-rOCT1, confirming a direct phosphorylation of this transporter (8) and the importance of these residues for the regulation of the transporter by PKC activation. The data suggest that all putative PKC sites can be endogenously phosphorylated, as shown by the decrease of apparent affinity for the tested substances in every mutant (Table 1) . However, endogenous phosphorylation of S286 and S292 influences the binding sites for TPA ϩ and, to a lower extent, for quinine, but not that for TEA ϩ . These modulations of the substrate affinity of rOCT1 depending on phosphorylation of the molecule may explain the differences in apparent substrate affinities of OCTs determined in different organs or species or after expression of cloned transporters in different cellular systems (8, 35) .
In conclusion, we demonstrated that the presence of all five potential PKC-phosphorylation sites in the intracellular domain of rOCT1 is essential for its regulation by PKC. These data suggested that the large intracellular loop of rOCT1 is part of the binding pocket or closely interacts with it and that under basal conditions rOCT1 is partially endogenously phosphorylated. Phosphorylation of different residues influences the binding site for various substrates differently and occurs at the S286, S292, T296, S328, and T550 residues.
